MAPT and Alzheimer disease: As brain samples from patients with Alzheimer’s disease contain other amyloid-containing deposits such as Aβ (amyloid-β), we performed a multiplex staining experiment using the anti-Aβ antibody 4G8, the anti-tau pS396 antibody and fluoroprobe L095.